Kanabo is creating a new standard in the medical cannabis industry by building a holistic ecosystem that works together in synergy to improve the well-being of millions around the world. We focus on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers. We have conducted extensive R&D in order to develop high-quality cannabis oil formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel an established leader in the cannabis industry.
|Non-Executive Director:||Uziel Danino, Dan Poulter|
|Non-Executive Chairman:||David Tsur|
|Independent Non-Executive Director:||Andrew John Gowdy Morrison|
|Address:||Churchill House, 137-139 Brent Street, London, United Kingdom|
|Phone:||+44 7980 878561|